# ICD-10

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/icd-10
Canonical HTML page: https://getbiobrief.com/entity/icd-10

## Recent coverage (1 stories)

### 2.75M Americans with CHS: Biotech Opportunity After 16% Diagnosis Jump
2026-08-07 15:53:57 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

With 2.75 million suffering from cannabis hyperemesis syndrome and a 16% jump in ED diagnoses after a new ICD code, an underserved patient population emerges. Biopharma companies can explore targeted therapies for CHS, a condition currently managed only with abstinence and supportive care, presenting a significant unmet medical need.
Full story: https://getbiobrief.com/story/cannabis-hyperemesis-pharma-opportunity

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.